$45,692.00, that is a very disturbing report. There are things I should like to say but discretion would indicate that I should not. It could be seen that such massive exchanges of money has the potential for "wickedness". Surely this could be seen to be inappropriate both professionally by the psychiatrists and in business terms by the American equivalent of our Food and Drug Directorate.

I find this report very troubling. These are all new drugs and any experienced physician knows by hard experience that the real nasty side effects of new medications may not appear for years. What has happened to clinical judgement and the appropriate use of the best proven intervention which may not be a drug at all?

__________________
George Neeson M.D.